OUTCOMES OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CARDIOGENIC SHOCK TREATED WITH CULPRIT VESSEL-ONLY VERSUS MULTIVESSEL PRIMARY PCI- A COMPARITIVE STUDY FROM TERTIARY CARE HOSPITAL

Authors

  • Dr Muhammad Irfan
  • Dr Tahir Mumtaz
  • Dr Manoj Kumar Bodani
  • Dr Jaghat Ram
  • Iram Jehan Balouch
  • Dr Sana Mehboob
  • Dr Salman Khan

DOI:

https://doi.org/10.53555/hh3srs29

Keywords:

.

Abstract

Introduction

The study aimed to compare the characteristics and prognosis of patients with Cardiogenic Shock STEMI  and multivessel coronary disease (MVD) treated with culprit vessel-only pPCI or multivessel-pPCI during the initial procedure

Material and methods

From 2016 to 2020  , 23,703 primary PCI patients with STEMI were included in a national all-comers registry of cardiovascular interventions. Of them, 1,213 (5.1%) patients had CS and MVD at admission to the hospital. Initially, 921 (75.9%) patients were treated with culprit vessel (CV)-pPCI and 292 (24.1%) with multivessel (MV)-pPCI.

Results

Patients with 3-vessel disease and left main disease had a higher probability of being treated with MV-pPCI than patients with 2-vessel disease and patients without left main disease (28.5% vs. 18.6%; p < 0.001 and 37.7% vs. 20.6%; p < 0.001). Intra-aortic balloon pump, extracorporeal membrane oxygenation (ECMO), and other mechanical circulatory support systems were more often used in patients with MV-pPCI. Thirty (30)-day and 1-year all-cause mortality rates were similar in the CV-pPCI and MV-pPCI groups (odds ratio, 1.01; 95% confidence interval [CI] 0.77 to 1.32; p = 0.937 and 1.1; 95% CI 0.84 to 1.44; p = 0.477). The presence of 3-vessel disease and the use of ECMO were the strongest adjusted predictors of 30-day and 1-year mortality.

Author Biographies

  • Dr Muhammad Irfan

    Clinical Fellow, NICVD Karachi, Pakistan 

  • Dr Tahir Mumtaz

    FCPS Resident, NICVD Karachi, 

  • Dr Manoj Kumar Bodani

    FCPS Resident, NICVD Karachi, Pakistan 

  • Dr Jaghat Ram

    MBBS, FCPS, Post Fellowship Interventional Cardiology, Assistant Professor Interventional Cardiology, National Institute of Cardiovascular Diseases Larkana Sind, Pakistan 

  • Iram Jehan Balouch

    Consultant Cardiologist, Hyderabad Satellite Centre of National Institute of Cardiovascular Disease, Pakistan 

  • Dr Sana Mehboob

    Postgraduate, Adult Cardiology NICVD Karachi, Pakistan 

  • Dr Salman Khan

    Clinical Fellow, NICVD Karachi, Pakistan 

References

1. M. Samsky, M. Krucoff, A.D. Althouse, et al.

Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock

Am Heart J, 219 (2020), pp. 1-8

View PDFView articleView in ScopusGoogle Scholar

2. N. Aissaoui, E. Puymirat, X. Tabone, et al.

Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries

Eur Heart J, 33 (2012), pp. 2535-2543

CrossrefView in ScopusGoogle Scholar

3. U. Zeymer, P. Ludman, N. Danchin, et al.

Reperfusion therapy for ST-elevation myocardial infarction complicated by cardiogenic shock: the European Society of Cardiology EurObservational programme acute cardiovascular care-European association of PCI ST-elevation myocardial infarction registry

Eur Heart J Acute Cardiovasc Care, 11 (2022), pp. 481-490

Crossref View in ScopusGoogle Scholar

4. H. Thiele, B. Allam, G. Chatellier, G. Schuler, A. Lafont

Shock in acute myocardial infarction: the Cape Horn for trials?

Eur Heart J, 31 (2010), pp. 1828-1835

CrossrefView in ScopusGoogle Scholar

5. H. Thiele, E.M. Ohman, S. de Waha-Thiele, U. Zeymer, S. Desch

Management of cardiogenic shock complicating myocardial infarction: an update 2019

Eur Heart J, 40 (2019), pp. 2671-2683

CrossrefView in ScopusGoogle Scholar

6. H.D. White, S.F. Assmann, T.A. Sanborn, et al.

Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial

Circulation, 112 (2005), pp. 1992-2001

View in ScopusGoogle Scholar

7. F.J. Neumann, M. Sousa-Uva, A. Ahlsson, et al.

2018 ESC/EACTS Guidelines on myocardial revascularization

Eur Heart J, 40 (2019), pp. 87-165

CrossrefView in ScopusGoogle Scholar

8. J.G. Webb, A.M. Lowe, T.A. Sanborn, et al.

Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial

J Am Coll Cardiol, 42 (2003), pp. 1380-1386

View PDFView articleView in ScopusGoogle Scholar

9. J.S. Hochman, L.A. Sleeper, J.G. Webb, et al.

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock

N Engl J Med, 341 (1999), pp. 625-634

View in ScopusGoogle Scholar

10. J.S. Park, K.S. Cha, D.S. Lee, et al.

Culprit or multivessel revascularisation in ST-elevation myocardial infarction with cardiogenic shock

Heart, 101 (2015), pp. 1225-1232

CrossrefView in ScopusGoogle Scholar

11. H. Thiele, I. Akin, M. Sandri, et al.

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

N Engl J Med, 377 (2017), pp. 2419-2432

CrossrefView in ScopusGoogle Scholar

12. J.S. Lawton, J.E. Tamis-Holland, S. Bangalore, et al.

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation, 145 (2022), pp. e18-e114

Google Scholar

13. M. Gąsior, P. Desperak, D. Dudek, et al.

Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock: CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry

J Clin Med, 10 (2021)

Google Scholar

14. www.uzis.cz.

Google Scholar

15. M. Zelizko, S. Drabkova, I. Kovacova, M. Mates

Development of percutaneous coronary interventions in the Czech Republic in 2005–2018. Results of the National Registry of Cardiovascular Interventions

Interv Akut Kardiol, 19 (2020), pp. 25-29

CrossrefView in ScopusGoogle Scholar

16. D.S. Wald, J.K. Morris, N.J. Wald, et al.

Randomized trial of preventive angioplasty in myocardial infarction

N Engl J Med, 369 (2013), pp. 1115-1123

CrossrefView in ScopusGoogle Scholar

17. A.H. Gershlick, J.N. Khan, D.J. Kelly, et al.

Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial

J Am Coll Cardiol, 65 (2015), pp. 963-972

View PDFView articleView in ScopusGoogle Scholar

18. T. Engstrøm, H. Kelbæk, S. Helqvist, et al.

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Lancet (London, England), 386 (2015), pp. 665-671

View PDFView articleView in ScopusGoogle Scholar

19. P.C. Smits, M. Abdel-Wahab, F.J. Neumann, et al.

Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction

N Engl J Med, 376 (2017), pp. 1234-1244

View in ScopusGoogle Scholar

20. S.R. Mehta, D.A. Wood, R.F. Storey, et al.

Complete Revascularization with Multivessel PCI for Myocardial Infarction

N Engl J Med, 381 (2019), pp. 1411-1421

CrossrefView in ScopusGoogle Scholar

21. P. Gaba, B.J. Gersh, Z.A. Ali, J.W. Moses, G.W. Stone

Complete versus incomplete coronary revascularization: definitions, assessment and outcomes

Nat Rev Cardiol, 18 (2021), pp. 155-168

CrossrefView in ScopusGoogle Scholar

22. L.F. Li, M. Qiu, S.Y. Liu, H.R. Zhou

Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease: A meta-analysis

Medicine, 100 (2021), Article e26251

CrossrefGoogle Scholar

23. H

Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularisation versus conservative strategy. Prague-13 trial

Kardiol Rev Int Med, 17 (2015), pp. 214-220

View in ScopusGoogle Scholar

24. Y. Ozaki, H. Hara, Y. Onuma, et al.

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

Cardiovasc Interv Ther, 37 (2022), pp. 1-34

CrossrefGoogle Scholar

25. D.A. Wood, J.A. Cairns, J. Wang, et al.

Timing of staged nonculprit artery revascularization in patients with st-segment elevation myocardial infarction: COMPLETE Trial

J Am Coll Cardiol, 74 (2019), pp. 2713-2723

View PDFView articleView in ScopusGoogle Scholar

26. V. Paradies, C. Waldeyer, P.L. Laforgia, P. Clemmensen, P.C. Smits

Completeness of revascularisation in acute coronary syndrome patients with multivessel disease

EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 17 (2021), pp. 193-201

CrossrefView in ScopusGoogle Scholar

27. Almeida, J. Chin, H. Santos, et al.

Revascularization strategies in STEMI and multivessel disease

Acta Cardiol (2021), pp. 1-8

View in ScopusGoogle Scholar

28. Y. Okuya, K. Gohil, I.D. Moussa

Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)

Google Scholar

29. E. Puymirat, G. Cayla, T. Simon, et al.

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction

N Engl J Med, 385 (2021), pp. 297-308

CrossrefView in ScopusGoogle Scholar

30. A.H. Gershlick, A.S. Banning, E. Parker, et al.

Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial

J Am Coll Cardiol, 74 (2019), pp. 3083-3094

View PDFView articleView in ScopusGoogle Scholar

31. J.P.M. Andrews, Z.A. Fayad, M.R. Dweck

New methods to image unstable atherosclerotic plaques

Atherosclerosis, 272 (2018), pp. 118-128

View PDFView articleView in ScopusGoogle Scholar

32. L. Galiuto, L. Leccisotti, G. Locorotondo, et al.

Coronary plaque instability assessed by positron emission tomography and optical coherence tomography

Ann Nucl Med, 35 (2021), pp. 1136-1146

CrossrefView in ScopusGoogle Scholar

33. P. Jüni

PCI for Nonculprit Lesions in Patients with STEMI - No Role for FFR

N Engl J Med, 385 (2021), pp. 370-371

CrossrefView in ScopusGoogle Scholar

34. S.J. Nicholls, R. Puri, T. Anderson, et al.

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

JAMA, 316 (2016), pp. 2373-2384

CrossrefView in ScopusGoogle Scholar

35. M.S. Sabatine, R.P. Giugliano, A.C. Keech, et al.

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

N Engl J Med, 376 (2017), pp. 1713-1722

CrossrefView in ScopusGoogle Scholar

36. G.G. Schwartz, P.G. Steg, M. Szarek, et al.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

N Engl J Med, 379 (2018), pp. 2097-2107

CrossrefView in ScopusGoogle Scholar

37. El Nasasra, U. Zeymer

Current clinical management of acute myocardial infarction complicated by cardiogenic shock

Downloads

Published

2024-07-22

How to Cite

Dr Muhammad Irfan, Dr Tahir Mumtaz, Dr Manoj Kumar Bodani, Dr Jaghat Ram, Iram Jehan Balouch, Dr Sana Mehboob, & Dr Salman Khan. (2024). OUTCOMES OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CARDIOGENIC SHOCK TREATED WITH CULPRIT VESSEL-ONLY VERSUS MULTIVESSEL PRIMARY PCI- A COMPARITIVE STUDY FROM TERTIARY CARE HOSPITAL. Journal of Population Therapeutics and Clinical Pharmacology, 31(7), 1766-1777. https://doi.org/10.53555/hh3srs29
More Citation Formats

Issue

Section

Articles

How to Cite

Dr Muhammad Irfan, Dr Tahir Mumtaz, Dr Manoj Kumar Bodani, Dr Jaghat Ram, Iram Jehan Balouch, Dr Sana Mehboob, & Dr Salman Khan. (2024). OUTCOMES OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CARDIOGENIC SHOCK TREATED WITH CULPRIT VESSEL-ONLY VERSUS MULTIVESSEL PRIMARY PCI- A COMPARITIVE STUDY FROM TERTIARY CARE HOSPITAL. Journal of Population Therapeutics and Clinical Pharmacology, 31(7), 1766-1777. https://doi.org/10.53555/hh3srs29

Most read articles by the same author(s)

1 2 > >>